Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial

A. K. Stewart, R. Vescio, G. Schiller, O. Ballester, S. Noga, H. Rugo, C. Freytes, E. Stadtmauer, S. Tarantolo, F. Sahebi, P. Stiff, J. Meharchard, R. Schlossman, R. Brown, H. Tully, M. Benyunes, C. Jacobs, R. Berenson, M. White, J. DipersioK. C. Anderson, J. Berenson

Research output: Contribution to journalArticle

164 Scopus citations

Fingerprint Dive into the research topics of 'Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences